Skånevård Nordost Region Skåne - Verksamhets område ortopedi, Kristianstad /Hässleholm
Hässleholm, Skåne County, Sweden
NCT Number: NCT04651673
The study is a non-controlled retro- and prospective multi center patient registry study.
Subjects will be given a study ID number assigned at first brace fitting after consenting to partake. Participants will be asked to fill in a questionnaire either in electronic or paper version at first fitting. Additional follow up questionnaires will be implemented at 4 weeks, 6 months and 1 year post initial brace fitting. After that period patients will be contacted every year, until brace termination/ knee surgery or death.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Hässleholm, Skåne County, Sweden
This is a noninterventional registry study pertaining to knee OA braces. There are no comparative devices or treatments. Subjects are expected to follow the recommendations of the brace subscriber and other health care professionals at any time independent of their continuation within the registry.
Subjects will be enrolled at the clinic where their brace was prescribed or at the site where the brace was fitted.
There is no formal end date for this data registry. A revisit to this protocol may be motivated after 5 years, to assess if longer follow up is required.
For individual participants follow up will continue with annual questionnaires as long as the brace is in use. The questionnaires will be administered either through mail with a paper version, or through a link to an electronical version (ePRO). There is also a possibility of administrating the questionnaires as a phone guided interview, if that is a mean that serves the patient or clinics better. The planned follow-ups are at 4 weeks, 6 months, 1 year from brace prescription and then annually as long as participants are disposed as "ongoing" in the registry.
The questionnaires contains question about pain, function, medication, general brace use and quality of life question.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients, at listed investigational sites, that get prescription for a knee orthosis indicated for Knee OA symptomatic treatment, get an invite to partake in the evaluation registry.
Time frame: 6 months follow up
brace usage, days per week
Time frame: 6 months follow up
Knee injury and Osteoarthritis Outcome Score (KOOS)-12
Time frame: 6 months follow up
KOOS-12
Time frame: 1 year follow up
brace usage, days per week
Time frame: 1 year follow up
KOOS-12
Time frame: 1 year follow up
KOOS-12
Time frame: 6 months follow up
Proportion of sick leave
Time frame: 1 year follow up
Proportion of sick leave
Time frame: 6 months follow up
KOOS-12
Time frame: 1 year follow up
KOOS-12
Time frame: 6 months follow up
EQ-5D-5L
Time frame: 1 year follow up
EQ-5D-5L
Time frame: 6 months follow up
Numeric Rating Scale (NRS) for satisfaction (0-10)
Time frame: 1 year follow up
NRS for satisfaction (0-10)
Össur Iceland ehf
Industry
Behandlingseffekter Med Avlastande knäortoser för Patienter Med knäartros En Retro-och Prospektiv Multicenterregisterstudie
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07652372
Arthritis, Joint Diseases
Beijin, China
View Trial DetailsNCT07504562
Arthritis, Joint Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06766877
Arthritis, Joint Diseases
Karachi, Sindh, Pakistan
View Trial DetailsNCT07395427
Arthritis, Behavior
Ankara, Turkey (Türkiye)
View Trial Details